Dov A. Md Goldstein
Director · Gain Therapeutics, Inc.
- 2025
- Jul 17, 2026
- 10
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Dov A. Md Goldstein files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Kristen Fortney - $4.22M in BIOA purchases and sales in the last 12 months
- Shane Barton - $1.58M in BIOA purchases and sales in the last 12 months
- Paul D. Rubin - $1.15M in BIOA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Dov A. Md Goldstein?
Dov A. Md Goldstein is a corporate insider, tracked as Director of Gain Therapeutics, Inc. (GANX). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Dov A. Md Goldstein last file a Form 4?
The most recent primary Form 4 on record is dated 17 July 2026, one of 10 filings going back to 2025.
Has Dov A. Md Goldstein been buying or selling stock?
Recorded transactions: 0 open-market purchases and 4 open-market sales ($532K) across all tracked filings.
